GlassScriptPhysician profile
Jayson Lavie
NPI 1689087009
$4,314.35
in general payments reported to CMS, 2019-2025
15 companies · $1,664 in 2025
The $1,664 reported for 2025 was more than what 89% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $236 · 2022: $961 · 2023: $760 · 2024: $692 · 2025: $1,664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,198 · Travel and Lodging: $918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,198.08 |
| Travel and Lodging | $918.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,363.87 | 2021-2025 | Pipeline, Solitaire X, Activos 10 Bone Cement |
| Balt USA, LLC | $965.67 | 2025 | Optima Coil System, Raptor Aspiration Catheter, Carrier Delivery Catheter |
| Microvention, INC. | $594.70 | 2022-2024 | Web Aneurysm Embolization System, Stent, Sofia 6f-131cm Str |
| Stryker Corporation | $406.48 | 2022-2025 | Surpass Evolve, Target, Axs Vecta 71 |
| Qapel Medical INC | $283.47 | 2024 | |
| Imperative Care, INC | $241.42 | 2023-2025 | Zoom Reperfusion Catheter, Zoom 88-T Large Distal Platform |
| Depuy Synthes Sales INC. | $115.62 | 2024-2025 | Trufill |
| Penumbra, INC. | $83.49 | 2023 | Penumbra System, Benchmark |
| Carlsmed, INC. | $70.89 | 2023 | Aprevo |
| Boston Scientific Corporation | $54.17 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $37.00 | 2022 | |
| Abbott Laboratories | $34.68 | 2022 | |
| Route 92 Medical, INC. | $33.05 | 2025 | |
| Curonix LLC | $16.33 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Ethicon US, LLC | $13.51 | 2025 | Surgiflo Hemostatic Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayson Lavie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.